当前位置: X-MOL首页全球导师 海外导师 › Ciani, Oriana

个人简介

2014 PhD Health Technology Assessment (UEMS) 2010 MSc Health Economics and Management (Bocconi University) 2008 MSc Bioengineering/ Biomedical Signal Processing (Politecnico di Milano) 2005 BSc Bioengineering (Politecnico di Milano)

研究领域

Oriana has a broad interest in comparative effectiveness research and meta-epidemiological studies, cost-effectiveness analyses as well as evidence synthesis and policy evaluation to inform decision-making. Oriana‘s specific research interests deal with the validation of surrogate endpoints to support licensing and coverage decisions of health technologies. She has also an interest in methods for the Health Technology Assessment of Medical Devices. Oriana has got experience in teaching postgraduate students about systematic reviews, evidence synthesis and methods for health technology assessment. She is coordinator of a module in Public Health for students at the Master in Health Economics, Policy and Management at SDA Bocconi.

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Ciani O, Armeni P, Boscolo PR, Cavazza M, Jommi C, Tarricone R (2016). De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making. Health Policy and Technology, 5(1), 47-64. Article has an altmetric score of 1 Ciani O, Arendsen E, Romancik M, Lunik R, Costantini E, Di Biase M, Morgia G, Fragalà E, Roman T, Bernat M, et al (2016). Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study. BMJ Open, 6(3). Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Taylor RS (2016). Validation of surrogate end points for overall survival in advanced colorectal cancer: a harmonized approach is needed. J Clin Epidemiol, 70, 277-278. Author URL. Generali D, Venturini S, Rognoni C, Ciani O, Pusztai L, Loi S, Jerusalem G, Bottini A, Tarricone R (2015). A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer. Breast Cancer Res Treat, 152(1), 95-117. Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Wilcher B, Blankart CR, Hatz M, Rupel VP, Erker RS, Varabyova Y, Taylor RS (2015). Health technology assessment of medical devices: a survey of non-European union agencies. Int J Technol Assess Health Care, 31(3), 154-165. Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS (2015). Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. J Clin Epidemiol, 68(7), 833-842. Abstract. Author URL. Taylor RS, Piepoli MF, Smart N, Coats AJS, Ellis S, Dalal H, O'Connor CM, Warren FC, Whellan D, Ciani O, et al (2014). Corrigendum to exercise training for chronic heart failure (ExTraMATCH II): Protocol for an individual participant data meta-analysis Int J Cardiol. 2014 Jul 1;174(3):683-7. International Journal of Cardiology Taylor RS, Piepoli MF, Smart N, Coats AJ, Ellis S, Dalal H, O'Connor CM, Warren FC, Whellan D, Ciani O, et al (2014). Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis. Int J Cardiol, 174(3), 683-687. Abstract. Author URL. Ciani O, Jommi C (2014). The role of health technology assessment bodies in shaping drug development. Drug Des Devel Ther, 8, 2273-2281. Abstract. Author URL. Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad ED, Buyse M, Taylor RS (2014). Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers. Int J Technol Assess Health Care, 30(3), 312-324. Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Grassi D, Tarricone R (2013). An economic perspective on urinary tract infection: the "costs of resignation". Clin Drug Investig, 33(4), 255-261. Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, Taylor RS (2013). Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ, 346 Abstract. Author URL. Ciani O, Hoyle M, Pavey T, Cooper C, Garside R, Rudin C, Taylor R (2013). Complete cytogenetic response and major molecular response as surrogate outcomes for overall survival in first-line treatment of chronic myelogenous leukemia: a case-study for technology appraisal on the basis of surrogate outcomes evidence. Value in Health, 6(16), 1081-1090. Ciani O, Taylor RS (2013). Surrogate, friend or foe? the need for case studies of the use of surrogate outcomes in cost-effectiveness analyses. Health Econ, 22(2), 251-252. Abstract. Author URL. Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad E, Buyse M, Taylor R (2013). VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMOURS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS. VALUE IN HEALTH, 16(7), A327-A327. Author URL. Pavey T, Hoyle M, Ciani O, Crathorne L, Jones-Hughes T, Cooper C, Osipenko L, Venkatachalam M, Rudin C, Ukoumunne O, et al (2012). Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: Systematic reviews and economic analyses. Health Technology Assessment, 16, 1-278. Abstract. Author URL. Mota RE, Tarricone R, Ciani O, Bridges JF, Drummond M (2012). Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res, 12 Abstract. Author URL. Article has an altmetric score of 1 Ciani O, Tarricone R, Torbica A (2012). Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?. Health Policy, 108(2-3), 194-202. Abstract. Author URL. Boscolo PR, Ciani O, Torbica A (2012). HOSPITAL-BASED HTA IN ITALY: DIFFUSION AND POTENTIAL IMPACT. VALUE IN HEALTH, 15(7), A283-A283. Author URL. Ciani O, Taylor RS (2011). A more evidence based approach to the use of surrogate end points in policy making. BMJ, 343 Author URL.

推荐链接
down
wechat
bug